Schonfeld Strategic Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 129,400 shares of PMVP stock, worth $222,568. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,400
Previous 141,788
8.74%
Holding current value
$222,568
Previous $241,000
13.28%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PMVP
# of Institutions
100Shares Held
43.4MCall Options Held
500Put Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$11.1 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.82 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.66 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.52 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$4.03 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $78.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...